Serotonin receptors are grouped into families identified as 5-HT1 through 5-HT7, with several subtypes. Most are G protein-coupled receptors; 5-HT3 is an ion channel. They differ in distribution, signalling and function. A drug’s action at one subtype should not be generalised to all serotonin receptors.

Serotonin is a neurotransmitter that acts through several receptor families in the brain and body. It influences many functions, including mood, sleep, appetite and sensory processing. Its role cannot be reduced to happiness, and different receptor actions can produce very different physiological or clinical effects even within the same medicine.

Antipsychotics commonly involve 5-HT2A and, for some drugs, 5-HT1A or 5-HT2C. Other measurable binding includes 5-HT6 and 5-HT7, but independent clinical contributions may remain uncertain. Receptor lists can suggest hypotheses about mood, cognition or appetite without proving them. Affinity also varies with assay conditions and does not by itself establish occupancy at a prescribed dose. Understanding the families provides a framework for comparison while reminding readers that the word serotonin describes a diverse system rather than one uniform effect.

Receptor families differ in their cellular mechanisms. Most serotonin receptors act through G proteins, whereas 5-HT3 directly forms an ion channel. Subtypes within a family also have distinct distributions. Learning the main distinctions is more useful than memorising a long list without context, because the same transmitter can influence many functions through different routes and interacting networks.

Further reading: DailyMed prescribing information (1); Research record 8935801; DailyMed prescribing information (3); DailyMed prescribing information (4).

Comments are closed, but trackbacks and pingbacks are open.